[News] Concurrent chemotherapy improves outcomes in HNSCC

The addition of concurrent chemotherapy to cetuximab plus radiotherapy in the treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) improves progression-free survival (PFS) compared with cetuximab and radiotherapy alone, according to a recent study.

https://ift.tt/2KjYYz0